Solventum Corp | SOLV - Beneficio Bruto En Ventas

Precio De Mercado
65.78
Cambio Diario
-1.36 -2.03%
Mensual
-9.46%
Anual
-11.07%
Q1 Expectativa
64.74




Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.54B 625M 2025-12
Align Technology USD 683.59M 44.39M 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Cencora USD 2.99B 31.87M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Insulet USD 568.6M 58.5M 2025-12
Solventum Corp USD 1.03B 108M 2025-12
West Pharmaceutical Services USD 303.9M 9.6M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12